A. Sanyal, S. Yoon, and R. Lencioni, The etiology of hepatocellular carcinoma and consequences for treatment. The oncologist, pp.14-22, 2010.

P. Song, R. Tobe, Y. Inagaki, N. Kokudo, K. Hasegawa et al., The management of hepatocellular carcinoma around the world: a comparison of guidelines from 2001 to 2011, Liver International, vol.4, issue.Suppl. 4, pp.1053-1063, 2001.
DOI : 10.1159/000218339

F. Mornex, N. Girard, C. Beziat, A. Kubas, M. Khodri et al., Feasibility and efficacy of high-dose three-dimensional-conformal radiotherapy in cirrhotic patients with small-size hepatocellular carcinoma non-eligible for curative therapies???mature results of the French Phase II RTF-1 trial, International Journal of Radiation Oncology*Biology*Physics, vol.66, issue.4, pp.1152-1158, 2006.
DOI : 10.1016/j.ijrobp.2006.06.015

H. Blomgren, I. Lax, I. Näslund, and R. Svanström, Stereotactic High Dose Fraction Radiation Therapy of Extracranial Tumors Using An Accelerator: Clinical experience of the first thirty-one patients, Acta Oncologica, vol.33, issue.52, pp.861-870, 1995.
DOI : 10.3109/02841869309093624

A. Jr, J. Chang, S. Murphy, M. Doty, J. Geis et al., The Cyberknife: a frameless robotic system for radiosurgery, Stereotact Funct Neurosurg, vol.69, pp.1-4124, 1997.

J. Bruix and M. Sherman, Management of hepatocellular carcinoma: An update, Hepatology, vol.10, issue.Suppl 1, pp.1020-1022, 2011.
DOI : 10.1016/S1470-2045(08)70285-7

G. Oldrini, H. Taste-george, S. Renard-oldrini, A. Baumann, V. Marchesi et al., Implantation of fiducial markers in the liver for stereotactic body radiation therapy: Feasibility and results. Diagn Interv Imaging, 2014.

T. Lawrence, J. Robertson, M. Anscher, R. Jirtle, W. Ensminger et al., Hepatic toxicity resulting from cancer treatment, International Journal of Radiation Oncology*Biology*Physics, vol.31, issue.5, pp.1237-1248, 1995.
DOI : 10.1016/0360-3016(94)00418-K

C. Pan, B. Kavanagh, L. Dawson, X. Li, S. Das et al., Radiation-Associated Liver Injury, International Journal of Radiation Oncology*Biology*Physics, vol.76, issue.3, pp.94-100, 2010.
DOI : 10.1016/j.ijrobp.2009.06.092

URL : http://europepmc.org/articles/pmc4388033?pdf=render

E. Eisenhauer, P. Therasse, J. Bogaerts, L. Schwartz, D. Sargent et al., New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1), European Journal of Cancer, vol.45, issue.2, pp.228-247, 1990.
DOI : 10.1016/j.ejca.2008.10.026

R. Lencioni and J. Llovet, Modified RECIST (mRECIST) Assessment for Hepatocellular Carcinoma, Seminars in Liver Disease, vol.30, issue.01, pp.52-60, 2010.
DOI : 10.1055/s-0030-1247132

J. Llovet, C. Brú, and J. Bruix, Prognosis of Hepatocellular Carcinoma: The BCLC Staging Classification, Seminars in Liver Disease, vol.19, issue.03, pp.329-338, 1999.
DOI : 10.1055/s-2007-1007122

P. Kamath, R. Wiesner, M. Malinchoc, W. Kremers, T. Therneau et al., A model to predict survival in patients with end-stage liver disease, Hepatology, vol.33, issue.2, pp.464-470, 2001.
DOI : 10.1053/jhep.2001.22172

E. Eortc, Clinical Practice Guidelines: Management of hepatocellular carcinoma, Eur J Cancer. mars, vol.48, issue.5, pp.599-641, 2012.

C. Verslype, O. Rosmorduc, and P. Rougier, on behalf of the ESMO Guidelines Working Group Hepatocellular carcinoma: ESMO-ESDO Clinical Practice Guidelines for diagnosis, treatment and follow-up, Ann Oncol, vol.23, issue.7, pp.41-48, 2012.

W. Jiang and Z. Zeng, Is It Time to Adopt External Beam Radiotherapy in the NCCN Guidelines as a Therapeutic Strategy for Intermediate/Advanced Hepatocellular Carcinoma?, Oncology, vol.14, issue.s1, pp.69-74, 2013.
DOI : 10.1111/j.1478-3231.2005.01170.x

M. Kudo, N. Izumi, N. Kokudo, O. Matsui, M. Sakamoto et al., Management of Hepatocellular Carcinoma in Japan: Consensus-Based Clinical Practice Guidelines Proposed by the Japan Society of Hepatology (JSH) 2010 Updated Version, JSH) 2010 Updated Version, pp.339-364, 2011.
DOI : 10.1159/000111702

A. Benson, T. Abrams, B. , E. Bloomston, P. Botha et al., Hepatobiliary Cancers, Journal of the National Comprehensive Cancer Network, vol.7, issue.4, pp.350-91, 2009.
DOI : 10.6004/jnccn.2009.0027

K. Herfarth, J. Debus, F. Lohr, M. Bahner, B. Rhein et al., Stereotactic Single-Dose Radiation Therapy of Liver Tumors: Results of a Phase I/II Trial, Journal of Clinical Oncology, vol.19, issue.1, pp.164-70, 2001.
DOI : 10.1200/JCO.2001.19.1.164

M. Romero, A. Wunderink, W. Hussain, S. , D. Pooter et al., Stereotactic body radiation therapy for primary and metastatic liver tumors: A single institution phase i-ii study, Acta Oncologica, vol.62, issue.1, pp.831-837, 2006.
DOI : 10.1016/j.ijrobp.2005.01.002

M. Romero, A. Wunderink, W. Van-os, R. Nowak, P. Heijmen et al., Quality of Life After Stereotactic Body Radiation Therapy for Primary and Metastatic Liver Tumors, International Journal of Radiation Oncology*Biology*Physics, vol.70, issue.5, pp.1447-1452, 2008.
DOI : 10.1016/j.ijrobp.2007.08.058

B. Choi, Fractionated Stereotactic Radiotherapy in Patients with Primary Hepatocellular Carcinoma, Japanese Journal of Clinical Oncology, vol.36, issue.3, pp.154-158, 2006.
DOI : 10.3109/02841869509127197

R. Tse, M. Hawkins, G. Lockwood, J. Kim, B. Cummings et al., Phase I Study of Individualized Stereotactic Body Radiotherapy for Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma, Journal of Clinical Oncology, vol.26, issue.4, pp.657-664, 2008.
DOI : 10.1200/JCO.2007.14.3529

K. Goodman, E. Wiegner, K. Maturen, Z. Zhang, Q. Mo et al., Dose-Escalation Study of Single-Fraction Stereotactic Body Radiotherapy for Liver Malignancies, International Journal of Radiation Oncology*Biology*Physics, vol.78, issue.2, pp.486-493, 2010.
DOI : 10.1016/j.ijrobp.2009.08.020

K. Goyal, D. Einstein, M. Yao, C. Kunos, F. Barton et al., Cyberknife Stereotactic Body Radiation Therapy for Nonresectable Tumors of the Liver: Preliminary Results, HPB Surgery, vol.1, issue.1, 2010.
DOI : 10.1093/jjco/hyi236

B. Choi, I. Choi, H. Jang, Y. Kang, J. Jang et al., Stereotactic body radiation therapy with or without transarterial chemoembolization for patients with primary hepatocellular carcinoma: preliminary analysis, BMC Cancer, vol.48, issue.1, p.351, 2008.
DOI : 10.1016/S0360-3016(00)00748-3

Y. Seo, M. Kim, S. Yoo, C. Cho, C. Choi et al., Preliminary result of stereotactic body radiotherapy as a local salvage treatment for inoperable hepatocellular carcinoma, Journal of Surgical Oncology, vol.76, issue.3, pp.209-214, 2010.
DOI : 10.1016/j.ijrobp.2009.02.027

J. Kang, M. Kim, C. Cho, K. Yang, H. Yoo et al., Stereotactic body radiation therapy for inoperable hepatocellular carcinoma as a local salvage treatment after incomplete transarterial chemoembolization, Cancer, vol.81, issue.21, pp.5424-5431, 2012.
DOI : 10.1016/j.ijrobp.2010.07.1986

J. Kwon, S. Bae, J. Kim, B. Choi, H. Jang et al., Long-term effect of stereotactic body radiation therapy for primary hepatocellular carcinoma ineligible for local ablation therapy or surgical resection. Stereotactic radiotherapy for liver cancer, BMC Cancer, vol.58, issue.suppl 1, p.475, 2010.
DOI : 10.1016/j.ijrobp.2003.08.012

W. Huang, J. Y. Lee, M. Chang, L. Chen, C. Ko et al., Stereotactic Body Radiation Therapy in Recurrent Hepatocellular Carcinoma, International Journal of Radiation Oncology*Biology*Physics, vol.84, issue.2, pp.355-361, 2012.
DOI : 10.1016/j.ijrobp.2011.11.058

W. Jang, M. Kim, S. Bae, C. Cho, H. Yoo et al., High-dose stereotactic body radiotherapy correlates increased local control and overall survival in patients with inoperable hepatocellular carcinoma, Radiation Oncology, vol.8, issue.1, p.250, 2013.
DOI : 10.1016/j.jhep.2012.05.007

J. Bibault, S. Dewas, C. Vautravers-dewas, A. Hollebecque, H. Jarraya et al., Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: Prognostic Factors of Local Control, Overall Survival, and Toxicity, PLoS ONE, vol.8, issue.10, p.77472, 2013.
DOI : 10.1371/journal.pone.0077472.s001

A. Takeda, N. Sanuki, T. Eriguchi, T. Kobayashi, S. Iwabutchi et al., Stereotactic ablative body radiotherapy for previously untreated solitary hepatocellular carcinoma, Journal of Gastroenterology and Hepatology, vol.76, issue.2, 2013.
DOI : 10.1016/j.ijrobp.2009.06.092

N. Sanuki, A. Takeda, Y. Oku, T. Mizuno, Y. Aoki et al., Stereotactic body radiotherapy for small hepatocellular carcinoma: A retrospective outcome analysis in 185 patients, Acta Oncologica, vol.10, issue.3, 2013.
DOI : 10.1007/s00535-007-2123-z

H. Cárdenes, T. Price, S. Perkins, M. Maluccio, P. Kwo et al., Phase I feasibility trial of stereotactic body radiation therapy for primary hepatocellular carcinoma, Clinical and Translational Oncology, vol.70, issue.3, pp.218-225, 2010.
DOI : 10.1016/j.ijrobp.2007.10.059

D. Andolino, C. Johnson, M. Maluccio, P. Kwo, A. Tector et al., Stereotactic Body Radiotherapy for Primary Hepatocellular Carcinoma, International Journal of Radiation Oncology*Biology*Physics, vol.81, issue.4, pp.447-453, 2011.
DOI : 10.1016/j.ijrobp.2011.04.011

A. Bujold, C. Massey, J. Kim, J. Brierley, C. Cho et al., Sequential Phase I and II Trials of Stereotactic Body Radiotherapy for Locally Advanced Hepatocellular Carcinoma, Journal of Clinical Oncology, vol.31, issue.13, pp.1631-1639, 2013.
DOI : 10.1200/JCO.2012.44.1659

A. Forner, C. Ayuso, M. Varela, J. Rimola, A. Hessheimer et al., Evaluation of tumor response after locoregional therapies in hepatocellular carcinoma, Cancer, vol.100, issue.3, pp.616-623, 2009.
DOI : 10.1093/jnci/djn134

M. Ronot, M. Bouattour, J. Wassermann, O. Bruno, C. Dreyer et al., Alternative Response Criteria (Choi, European Association for the Study of the Liver, and Modified Response Evaluation Criteria in Solid Tumors [RECIST]) Versus RECIST 1.1 in Patients With Advanced Hepatocellular Carcinoma Treated With Sorafenib, The Oncologist, vol.19, issue.4, 2014.
DOI : 10.1634/theoncologist.2013-0114

H. Jarraya, X. Mirabel, S. Taieb, S. Dewas, E. Tresch et al., Image-based response assessment of liver metastases following stereotactic body radiotherapy with respiratory tracking, Radiation Oncology, vol.8, issue.1, p.24, 2013.
DOI : 10.2214/ajr.165.1.7785638

J. Bruix, M. Sherman, J. Llovet, M. Beaugrand, R. Lencioni et al., Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL Conference, Journal of Hepatology, vol.35, issue.3, pp.421-430, 2001.
DOI : 10.1016/S0168-8278(01)00130-1

T. Price, S. Perkins, K. Sandrasegaran, M. Henderson, M. Maluccio et al., Evaluation of response after stereotactic body radiotherapy for hepatocellular carcinoma, Cancer, vol.9, issue.2 suppl, pp.3191-3198, 2012.
DOI : 10.1053/jlts.2003.50147

S. Yoon, Y. Lim, M. Park, S. Kim, B. Cho et al., Stereotactic Body Radiation Therapy as an Alternative Treatment for Small Hepatocellular Carcinoma, PLoS ONE, vol.12, issue.11, p.79854, 2013.
DOI : 10.1371/journal.pone.0079854.t003

J. Shim, H. Lee, S. Kim, Y. Shin, K. Kim et al., Which Response Criteria Best Help Predict Survival of Patients with Hepatocellular Carcinoma Following Chemoembolization? A Validation Study of Old and New Models, Radiology, vol.262, issue.2, pp.708-718, 2012.
DOI : 10.1148/radiol.11110282

D. Amico, G. Garcia-tsao, G. Pagliaro, and L. , Natural history and prognostic indicators of survival in cirrhosis: A systematic review of 118 studies, Journal of Hepatology, vol.44, issue.1, pp.217-231, 2006.
DOI : 10.1016/j.jhep.2005.10.013

A. Riaz, R. Ryu, L. Kulik, M. Mulcahy, R. Lewandowski et al., Alpha-Fetoprotein Response After Locoregional Therapy for Hepatocellular Carcinoma: Oncologic Marker of Radiologic Response, Progression, and Survival, Journal of Clinical Oncology, vol.27, issue.34, pp.5734-5742, 2009.
DOI : 10.1200/JCO.2009.23.1282

S. Chan, F. Mo, P. Johnson, E. Hui, B. Ma et al., New Utility of an Old Marker: Serial ??-Fetoprotein Measurement in Predicting Radiologic Response and Survival of Patients With Hepatocellular Carcinoma Undergoing Systemic Chemotherapy, Journal of Clinical Oncology, vol.27, issue.3, pp.446-452, 2009.
DOI : 10.1200/JCO.2008.18.8151

S. Vora, H. Zheng, Z. Stadler, C. Fuchs, and A. Zhu, Serum alpha-fetoprotein response as a surrogate for clinical outcome in patients receiving systemic therapy for advanced hepatocellular carcinoma. The oncologist, juill, vol.14, issue.7, pp.717-725, 2009.

B. Kim, S. Ahn, J. Seong, J. Park, D. Kim et al., Early ??-fetoprotein response as a predictor for clinical outcome after localized concurrent chemoradiotherapy for advanced hepatocellular carcinoma, Liver International, vol.12, issue.3, pp.369-376, 2011.
DOI : 10.1038/sj.onc.1209706

W. Kao, Y. Chiou, H. Hung, C. Su, Y. Chou et al., Serum alpha-fetoprotein response can predict prognosis in hepatocellular carcinoma patients undergoing radiofrequency ablation therapy, Clinical Radiology, vol.67, issue.5, pp.429-436, 2012.
DOI : 10.1016/j.crad.2011.10.009

N. Personeni, S. Bozzarelli, T. Pressiani, L. Rimassa, M. Tronconi et al., Usefulness of alpha-fetoprotein response in patients treated with sorafenib for advanced hepatocellular carcinoma, Journal of Hepatology, vol.57, issue.1, pp.101-107, 2012.
DOI : 10.1016/j.jhep.2012.02.016

B. Kavanagh, C. Pan, L. Dawson, S. Das, X. Li et al., Radiation Dose???Volume Effects in the Stomach and Small Bowel, International Journal of Radiation Oncology*Biology*Physics, vol.76, issue.3, pp.101-107, 2010.
DOI : 10.1016/j.ijrobp.2009.05.071

T. Schefter, B. Kavanagh, R. Timmerman, H. Cardenes, A. Baron et al., A phase I trial of stereotactic body radiation therapy (SBRT) for liver metastases, International Journal of Radiation Oncology*Biology*Physics, vol.62, issue.5, pp.1371-1378, 2005.
DOI : 10.1016/j.ijrobp.2005.01.002

S. Son, B. Choi, M. Ryu, Y. Kang, J. Jang et al., Stereotactic Body Radiotherapy for Patients With Unresectable Primary Hepatocellular Carcinoma: Dose-Volumetric Parameters Predicting the Hepatic Complication, International Journal of Radiation Oncology*Biology*Physics, vol.78, issue.4, pp.1073-1080, 2010.
DOI : 10.1016/j.ijrobp.2009.09.009

J. Jung, S. Yoon, S. Kim, B. Cho, J. Park et al., Radiation-induced liver disease after stereotactic body radiotherapy for small hepatocellular carcinoma: clinical and dose-volumetric parameters, Radiation Oncology, vol.8, issue.1, p.249, 2013.
DOI : 10.1016/j.ijrobp.2004.05.048

O. Connor, J. Trotter, J. Davis, G. Dempster, J. Klintmalm et al., Long-term outcomes of stereotactic body radiation therapy in the treatment of hepatocellular cancer as a bridge to transplantation, Liver Transplantation, vol.34, issue.8, pp.949-954, 2012.
DOI : 10.1097/COC.0b013e3181ec63ae

M. Facciuto, M. Singh, C. Rochon, J. Sharma, C. Gimenez et al., Stereotactic body radiation therapy in hepatocellular carcinoma and cirrhosis: Evaluation of radiological and pathological response, Journal of Surgical Oncology, vol.12, issue.7, pp.692-698, 2012.
DOI : 10.1016/j.canrad.2008.04.011

Z. Yuan, L. Tian, Q. Pang, Y. Song, Y. Dong et al., Comparative research on the efficacy of CyberKnife® and surgical excision for Stage I hepatocellular carcinoma. OncoTargets Ther, oct, vol.1527, 2013.

M. Pompili, A. Saviano, N. De-matthaeis, A. Cucchetti, F. Ardito et al., Long-term effectiveness of resection and radiofrequency ablation for single hepatocellular carcinoma ???3cm. Results of a multicenter Italian survey, Journal of Hepatology, vol.59, issue.1, pp.89-97, 2013.
DOI : 10.1016/j.jhep.2013.03.009

J. Zhong, B. Xiang, W. Gong, Y. Ke, Q. Mo et al., Comparison of Long-Term Survival of Patients with BCLC Stage B Hepatocellular Carcinoma after Liver Resection or Transarterial Chemoembolization, PLoS ONE, vol.55, issue.7, p.68193, 2013.
DOI : 10.1371/journal.pone.0068193.t004

A. Cucchetti, radiofrequency ablation for hepatocellular carcinoma, World Journal of Gastroenterology, vol.19, issue.26, p.4106, 2013.
DOI : 10.3748/wjg.v19.i26.4106

B. Decadt and A. Siriwardena, Radiofrequency ablation of liver tumours: systematic review, The Lancet Oncology, vol.5, issue.9, pp.550-560, 2004.
DOI : 10.1016/S1470-2045(04)01567-0

A. Ayav, A. Germain, F. Marchal, I. Tierris, V. Laurent et al., Radiofrequency ablation of unresectable liver tumors: factors associated with incomplete ablation or local recurrence, The American Journal of Surgery, vol.200, issue.4, pp.435-439, 2010.
DOI : 10.1016/j.amjsurg.2009.11.009

URL : https://hal.archives-ouvertes.fr/hal-00521310

J. Kim, J. Kim, H. Won, Y. Shin, H. Yoon et al., Hepatocellular carcinomas 2???3cm in diameter: Transarterial chemoembolization plus radiofrequency ablation vs. radiofrequency ablation alone, European Journal of Radiology, vol.81, issue.3, pp.189-193, 2012.
DOI : 10.1016/j.ejrad.2011.01.122

S. Mulier, P. Mulier, Y. Ni, Y. Miao, B. Dupas et al., Complications of radiofrequency coagulation of liver tumours, British Journal of Surgery, vol.217, issue.10, pp.1206-1222, 2002.
DOI : 10.1148/radiology.217.1.r00se02119

T. Livraghi, L. Solbiati, M. Meloni, G. Gazelle, E. Halpern et al., Treatment of Focal Liver Tumors with Percutaneous Radio-frequency Ablation: Complications Encountered in a Multicenter Study, Radiology, vol.226, issue.2, pp.441-451, 2003.
DOI : 10.1148/radiol.2262012198